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Abstract 20 
Liver fluke infection caused by Opisthorchis viverrini remains a major public health 21 
problem in many parts of Asia including Thailand, Lao PDR, Vietnam and Cambodia, where 22 
there is a strikingly high incidence of cholangiocarcinoma (CCA - hepatic cancer of the bile 23 
duct epithelium). Among other factors, uptake of O. viverrini excretory/secretory products 24 
(OvES) by biliary epithelial cells has been postulated to be responsible for chronic 25 
inflammation and proliferation of cholangiocytes, but the mechanisms by which cells 26 
internalize OvES are still unknown. Herein we incubated normal human cholangiocytes 27 
(H69), human cholangiocarcinoma cells (KKU-100, KKU-M156) and human colon cancer 28 
(Caco-2) cells with OvES and analysed the effects of different endocytic inhibitors to address 29 
the mechanism of cellular uptake of ES proteins. OvES was internalized preferentially by 30 
liver cell lines, and most efficiently/rapidly by H69 cells. There was no evidence for 31 
trafficking of ES proteins to cholangiocyte organelles, and most of the fluorescence was 32 
detected in the cytoplasm. Pretreatment with clathrin inhibitors significantly reduced the 33 
uptake of OvES products, particularly by H69 cells. OvES induced proliferation of liver cells 34 
(H69 and CCA lines) but not intestinal (Caco-2) cells, and proliferation was blocked using 35 
inhibitors of the classical endocytic pathways (clathrin and caveolae). OvES drove IL-6 36 
secretion by H69 cells but not Caco-2 cells, and cytokine secretion was significantly reduced 37 
by endocytosis inhibitors. This the first study to address the endocytosis of helminths ES 38 
proteins by host epithelial cells and sheds light on the pathways by which this parasite causes 39 
one of the most devastating forms of cancer in SE Asia. 40 
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1. Introduction  44 
Opisthorchiasis caused by infection with the carcinogenic liver fluke, Opisthorchis 45 
viverrini, remains an important health problem in Laos, Cambodia, Vietnam and Thailand, 46 
where >10 million people are infected (Sithithaworn et al., 2012). Humans acquire the 47 
infection by eating raw or undercooked cyprinoid fish, which act as the secondary 48 
intermediate host containing infective metacercariae (Kaewpitoon et al., 2008; Sripa et al., 49 
2011). Adult worms inhabit the biliary system of the mammalian host where they can survive 50 
for many years (Kaewpitoon et al., 2008). Chronic O. viverrini infection is associated with 51 
several hepatobiliary diseases including cholangitis, biliary hyperplasia, periductal fibrosis 52 
and cholangiocarcinoma (CCA), a fatal type of bile duct cancer (Sripa et al., 2012a; Sripa et 53 
al., 2007). Indeed, the north-east region of Thailand where O. viverrini is endemic has the 54 
highest worldwide incidence of CCA (Sripa and Pairojkul, 2008). 55 
O. viverrini-induced biliary pathology includes mechanical damage caused by the 56 
parasite’s physical attachment to and grazing on the biliary epithelium, the release of 57 
excretory/secretory products (OvES), and immunopathology (Sripa, 2003; Sripa et al., 58 
2012a). Indeed, immune-mediated pathogenesis in response to liver fluke infection is a major 59 
driving force in the onset of biliary disease, including CCA (Sripa et al., 2012a; Sripa et al., 60 
2007). OvES released from the tegument and excretory openings of the fluke are highly 61 
immunogenic (Choi et al., 2003; Sripa and Kaewkes, 2000a, b; Wongratanacheewin et al., 62 
1988). Sripa and Kaewkes (Sripa and Kaewkes, 2000a) observed an intense inflammatory 63 
response in areas of the biliary epithelium where parasite antigens were present, particularly 64 
those tissues in contact with the fluke. Moreover, numerous studies have provided evidence, 65 
albeit with low-resolution microscopy, that fluke antigens are detected inside cholangiocytes 66 
lining the biliary epithelium in O. viverrini-infected hamsters (Pinlaor et al., 2009; Smout et 67 
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al., 2009; Sripa and Kaewkes, 2000a). Until now, the mechanism by which liver fluke 68 
antigens are internalised by cholangiocytes remained elusive.  69 
Endocytosis is a major pathway for cell-cell communication and internalisation of 70 
extracellular proteins in eukaryotic organisms (Doherty and McMahon, 2009). Two major 71 
pathways have been described: (i) clathrin mediated endocytosis whereby molecules are 72 
uptaken via clathrin-coated vesicles, and (ii) non-clathrin mediated endocytosis (or caveolae-73 
mediated endocytosis) which requires cholesterol/sphingolipid-rich caveolae in membrane 74 
invagination and internalization (Le Roy and Wrana, 2005). The clathrin pathway controls 75 
targeting of signaling molecules to specialized membrane compartments (Ceresa and Schmid, 76 
2000), while the caveolae mediated pathway acts as a regulator of cell signaling (Lipkowitz, 77 
2003). In this study we used state-of-the-art microscopy techniques to investigate the 78 
internalisation mechanisms of OvES by human cholangiocytes and its function, particularly 79 
in cell proliferation and inflammatory cytokine IL-6 production. This may lead to better 80 
understanding of the pathogenesis of O. viverrini-induced hepatobiliary pathology and CCA.  81 
 82 
2. Materials and methods 83 
2.1 Chemicals 84 
Bovine serum albumin and all cellular process inhibitors [protease inhibitor E64, 85 
chlorpromazine (CPZ, a cationic amphiphilic inhibitor acts on clathrin-coated pits), sucrose 86 
(hypertonic media that interferes with clathrin and adaptor protein interactions), bafilomycine 87 
A1 and filipin] were purchased from Sigma. ER-Tracker™Red, BODIPY TR C5-ceramide, 88 
LysoTracker, mouse anti-Rad5, Hoechst, propidium iodide, Alexa Fluor 488 and carboxylic 89 
acid succinimidyl ester were obtained from Molecular Probes.  90 
 91 
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2.2 Parasites, animal infections and ethics approvals 92 
O. viverrini metacercariae were obtained from naturally infected cyprinoid fish 93 
captured from an endemic area in Khon Kaen province, Northeast Thailand, as described 94 
previously (Ninlawan et al., 2010). Briefly, fish were digested with pepsin-HCl, and after 95 
several washes with normal saline, metacercariae were collected, identified under a dissecting 96 
microscope and used to infect hamsters. Adult O. viverrini worms were obtained from the 97 
liver, gallbladders and extrahepatic bile ducts of hamsters infected for 3 months. All the 98 
hamsters used for this study were maintained at the animal facility, Faculty of Medicine, 99 
Khon Kaen University, and the protocols used for animal experimentation were approved by 100 
the Animal Ethics Committee of Khon Kaen University based on the Ethics of Animal 101 
Experimentation of the National Research Council of Thailand. 102 
 103 
2.3 Preparation of parasite ES products  104 
OvES was prepared as previously described with minor modifications (Sripa and 105 
Kaewkes, 2000a, b). Briefly, fresh worms were cultured in RPMI-1640 containing antibiotic 106 
and the protease inhibitor E64. Worms were maintained in vitro at 37°C and supernatants 107 
containing the OvES were collected twice each day for up to 7 days and centrifuged at 2,090 108 
g for 10 min to remove the eggs. The clarified supernatants were pooled, dialyzed in PBS, 109 
concentrated and absorbed with Triton-X114 to remove residual lipopolysaccharide (LPS) 110 
(Aida and Pabst, 1990), followed by Bio-Beads SM2 (Bio-Rad) to remove Triton-X114. 111 
Finally, OvES was filtered through a 0.2 μm membrane and then aliquoted and stored at -112 
80°C. The LPS concentration was determined by Limulus amoebacyte assay (less than 100 113 




2.4 Fluorescent labeling of OvES proteins. 117 
OvES proteins were labeled with Alexa Fluor 488 (Invitrogen) following the 118 
manufacturer’s protocol.  Briefly, 0.5 ml of 2 mg/ml OvES was gently mixed with 50 µl of 119 
1.0 mg/ml Alexa Fluor 488 in DMSO for 1 h at room temperature (RT). A G10 gel filtration 120 
column (Amersham Biosciences) was used to isolate labeled proteins from unbound dye. The 121 
protein concentration was measured by Bradford assay (Bio-Rad), and labeled protein was 122 
kept at 4°C until required for cell culture. 123 
2.5 Cell culture 124 
Normal human cholangiocytes (H69) were maintained in Dulbecco’s Modified Eagle 125 
Medium (DMEM/ HamF-12) (Gibco) supplemented with insulin, adenine, epinephrine, T3-T, 126 
epidermal growth factors (EGF) and hydrocortisone (Ninlawan et al., 2010). Human 127 
cholangiocarcinoma (KKU-100 and KKU-M156) were maintained in Ham-F12 (Gibco) and 128 
human colon cancer (Caco-2) cell lines were maintained in Dulbecco’s Modified Eagle 129 
Medium (DMEM) containing L-gutamine and non-essentails amino acids (Gibco) with  at 130 
37°C, 5% CO2 with 10% fetal calf serum (Gibco) containing 100 U/ml penicillin and 100 131 
µg/ml streptomycin solution (Gibco). 132 
2.6 Internalization of OvES 133 
To determine the uptake of OvES by cells, H69, KKU-100, KKU-M156 and Caco-2 134 
cell lines were incubated with 10 µg/ml unlabeled OvES at 37ºC. The cells were collected at 135 
different time points (0, 15, 30, 45, 60 min), washed in PBS, fixed with cold 4% 136 
paraformaldehyde for 20 min at RT and permeabilised with 0.1% Triton X-100 for 15 min. 137 
The cells were then blocked for nonspecific binding with 3% BSA in PBS for 20 min and 138 
incubated with rabbit anti-ES antiserum (Sripa and Kaewkes, 2000a) diluted 1: 300 with 1% 139 
BSA in PBS for 1 h, followed by goat anti-rabbit-Alexa Fluor 488 (Invitrogen) for 1 h. 140 
Nuclei were stained with propidium iodide or Hoechst and samples were viewed under a 141 
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confocal microscope (Olympus-FV1000 or Zeiss, LSM 700) and a 3D structure illumination 142 
microscope (SIM) for providing orthogonal views using Zen 2009 software (©Carl Zeiss 143 
MicroImaging GmbH). The total intracellular fluorescence was quantified by manually 144 
drawing a region of interest around the cytoplasm and analyzed using FV10-ASW V.2.1 145 
software (Olympus). 146 
Internalization of OvES was also analyzed by flow cytometry. Briefly, OvES co-147 
cultured cells were trypsinised, permealised and immunostained as above. After thorough 148 
washing with PBS the cells were examined using a flow cytometer (FC 500, Beckman 149 
Coulter, Inc., USA) and data was analyzed with FlowJo software (Tree Star, Inc., USA). For 150 
inhibition experiments, cells were pretreated with the following endocytosis inhibitors for 30 151 
min prior to adding 10 µg/ml OvES: 5 µg/ml chlorpromazine (CPZ), 0.3 M sucrose, or 4 152 
µg/ml filipin. All experiments were performed in triplicate and data are expressed as mean-153 
S.E. Statistical differences were determined using one-way analysis of variance using 154 
GraphPad Prism
TM
 V.5.3. P<0.05 was considered as significant for rejection of the null 155 
hypothesis. 156 
2.7 IL-6 production 157 
H69 and Caco-2 cells were seeded at 2,000 cells/well in complete media as described 158 
above for 24 h and starved for 12 h in media without serum prior to subsequent experiments. 159 
Cells were pretreated with endocytosis inhibitors (5 μg/ml CPZ, 4 µg/ml filipin and 1 nM 160 
bafilimycin A1) for 30 min, and subsequently cultured with 1.2 µg/ml OvES for 48 h. Cells 161 
incubated with and without OvES proteins and endocytosis inhibitors were used as controls. 162 
The culture media was collected and centrifuged at 929 g for 10 min to remove cell debris.  163 
Supernatant was then collected and IL-6 levels determined using a human IL-6 ELISA kit 164 
(R&D Systems) following the manufacturer’s recommendations. 165 
 166 
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2.8 Subcellular localization of OvES in biliary cells 167 
To determine OvES uptake and trafficking, H69, KKU-100 and KKU-M156 cells 168 
were pretreated with the following specific organelle-trackers: Endoplasmic reticulum (ER) - 169 
ER-Tracker™Red; Lysosomes – LysoTracker; Golgi - BODIPY TR C5-ceramide; early 170 
endosomes - anti-Rab5. Cells were stained with Hoechst dye for 30 min before incubating 171 
with Alexa Flour 488-conjugated OvES (10 µg/ml) for 2 h. After three rounds of washing, 172 
cells were fixed in cold 4% paraformaldehyde for 20 min at RT, mounted in 80% glycerol 173 
and viewed on a Nikon A1 confocal fluorescence microscope, equipped with a 60x (NA1.4 174 
plan Apo) oil immersion objective.  Z series images were collected in three channels (Ex 405 175 
nm, Em 425-475 nm; Ex 488 nm, Em 500-550 nm; Ex 561 nm, Em 570-620 nm) with a step 176 
size of 200 nm. 177 
2.9 Effect of OvES and endocytosis inhibitors on cell proliferation  178 
To test the effect of OvES and various endocytosis inhibitors on cell proliferation, 179 
real-time monitoring of cell growth using an xCELLigence system (Roche) was employed. 180 
Briefly, cells were seeded (2,000 cells/well) in an E plate (Roche) for 24 h. Cells were treated 181 
with the clathrin-specific inhibitor CPZ (5 µg/ml CPZ) for 30 min and, subsequently, 1.2 182 
µg/ml OvES was added and incubated for 48 h. Cells treated only with OvES (and not with 183 
inhibitors) were used as controls. Real-time cell growth was measured as cell index (CI) as 184 
previously described (Xing et al., 2005). 185 
 186 
3. Results 187 
3.1. Internalization of OvES by cancerous and non-cancerous biliary cell lines 188 
To study the internalization of OvES into biliary cells, different cell lines (H69, KKU-189 
100, KKU-M156 and Caco-2) were cultured with OvES and visualized at different time-190 
points using confocal microscopy (FV100). Internalization rates of OvES proteins were 191 
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dependent on the cell type. For the first 15 min, OvES proteins were internalized by H69 and 192 
KKU-M156 cell lines and were attached to the surface membranes of KKU-100 cells, but, in 193 
contrast, significantly less fluorescence was detected on or inside of Caco-2 cells (Fig. 1A), 194 
suggesting that OvES internalization is cell type-dependent. To validate the internalization of 195 
OvES products by H69 cholangiocytes in 3 dimensions, we performed a 3D image analysis, 196 
with the orthogonal view of the Z-stack 3D-SIM imaging (Fig. 1B-D). Orthogonal views 197 
confirmed that labeled OvES was attached to the cholangiocyte plasma membrane within 15 198 
min and detected in the cell cytoplasm after 60 min.  199 
Using flow cytometry, we found that significantly greater quantities of OvES were 200 
detected inside cells of hepatic origin (H69, KKU-100 and KKU-156) compared to control 201 
colon-derived Caco-2 cells (Fig. 2). The maximum fluorescence intensity was detected in 202 
H69 cholangiocytes after 2 h of co-culture (Supplementary Fig. 1).  203 
3.2 OvES uptake by cholangiocytes is via clathrin-mediated endocytosis 204 
To investigate the pathway(s) implicated in OvES internalization by host cells, 205 
different endocytosis inhibitors were employed – sucrose, filipin and CPZ. Cells were treated 206 
with filipin, sucrose or CPZ for 30 min, following incubation with OvES at 37ºC for 2 h and 207 
imaged using a confocal microscope. CPZ and sucrose inhibited OvES protein internalization 208 
by cholangiocytes and cholangiocyte-derived cancer cells (H69, KKU-100 and KKU-M156) 209 
(Fig. 3). Treatment of H69 cells with CPZ, sucrose and filipin resulted in 52-64% decrease of 210 
OvES uptake (Fig. 4). In contrast, CPZ and sucrose were more effective at preventing uptake 211 
of OvES by KKU-100 and KKU-M156 CCA cell lines than was filipin (Fig. 4). Total 212 
fluorescence calculation also showed that CPZ and sucrose inhibited OvES internalization 213 
(Supplementary Fig. 2A-C). These results suggest that OvES proteins are internalized by 214 
cholangiocytes via clathrin- and caveolae-mediated endocytosis pathways. 215 
 216 
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3.3. Cellular translocation of OvES proteins  217 
To investigate OvES intracellular localization within cholangiocytes, Alexa Flour 218 
488-conjugated OvES products were cultured with H69 cholangiocytes and different 219 
organelles were stained with specific fluorescent dyes. Using confocal microscopy, there was 220 
no evidence of OvES co-localization with Golgi, early endosomes, lysosomes, ER or nuclei, 221 
suggestive of a cytoplasmic location (Fig. 5).  222 
3.4. Endocytosis of OvES proteins modulates cell proliferation and pro-inflammatory 223 
cytokine production. 224 
To determine whether endocytosis of OvES proteins by cholangiocytes promoted cell 225 
proliferation we monitored cell proliferation in real-time using an xCelligence system (Xing 226 
et al., 2005). H69 cholangiocytes, KKU-100 and KKU-M156 CCA cell lines and the Caco-2 227 
colon cancer cell line were incubated with 1.2 µg/ml OvES products in the presence or 228 
absence of CPZ and monitored for 48 h. ES products promoted proliferation of all three 229 
cholangiocyte-derived cell lines (H69 and the CCA lines) but not the colon-derived Caco-2. 230 
In the presence of CPZ, OvES stimulated proliferation of the two CCA lines within the first 231 
48 hours of co-culture but thereafter significantly attenuated proliferation (Fig. 6A-C), while 232 
drug alone had no effect on cell growth (data not shown). Interestingly, OvES had no effect 233 
on proliferation of Caco-2 cells (Fig. 6D). 234 
It has been previously described that interleukin (IL)-6 is a pro-inflammatory cytokine 235 
associated with advanced periductal fibrosis in O. viverrini infected patients (Sripa et al., 236 
2009; Sripa et al., 2012b). IL-6 production from both cholangiocytes and colon cancer cells 237 
incubated with and without endocytosis inhibitors (CPZ, filipin and bafilomycin A1) before 238 
addition of OvES was measured. Addition of OvES promoted IL-6 production by 239 
cholangiocytes but had no effect on IL-6 production by Caco-2 cells (Fig. 7A). Moreover, all 240 
endocytosis inhibitors attenuated cholangiocyte IL-6 production by 69%, 55% and 53%, 241 
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respectively, with the greatest reduction occurring in the presence of the clathrin-mediated 242 
endocytosis inhibitor, CPZ (P< 0.001; Fig. 7B).   243 
 244 
4. Discussion 245 
The metabolic products secreted from the tegument and excretory openings of O. 246 
viverrini are highly immunogenic and have diverse effects on host cells (Sripa, 2003). 247 
Perhaps the most intriguing aspect of the interactions between OvES and human host 248 
cholangiocytes is the active internalization of ES proteins, and the potential carcinogenic 249 
ramifications of this process. We have shown previously that OvES proteins can be detected 250 
inside biliary epithelial cells in the vicinity of O. viverrini in the bile ducts of infected 251 
hamsters. Moreover, ES products were detected inside epithelial cells in the upper biliary tree 252 
where adult flukes are too large to reach (Sripa and Kaewkes, 2000a). Since this initial 253 
description, we and others raised antibodies to defined recombinant OvES products and 254 
showed that individual ES products, including thioredoxin peroxidase (Laha et al., 2007), 255 
granulin (Smout et al., 2009) and cathepsin F (Pinlaor et al., 2009) were internalized by 256 
cholangiocytes. While other pathogens have been shown to produce proteins that are 257 
internalized by host cells whereupon they induce toxic and functional changes, including pre-258 
cancerous events, this is the first evidence of the uptake by host cells of a secreted parasite 259 
protein. The bacterium Helicobacter pylori secretes cag A, a virulence factor whose uptake 260 
by epithelial cells can result in gastric cancer (Hatakeyama, 2004). Given that OvES products 261 
induce severe inflammation by up-regulation of cholangiocyte TLR4 mRNA expression, 262 
thereby promoting IL-6 and IL-8 production (Ninlawan et al., 2010), it is reasonable to 263 
assume that internalized OvES products also promote a tumorigenic phenotype. 264 
We show herein that OvES was internalized by cholangiocytes but not by the Caco-2 265 
line of intestinal epithelial cells (IEC). IEC serve as a critical barrier to luminal bacteria and 266 
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food, and are an active participant in the intestinal innate immune response, responding to 267 
signals in both the luminal (apical) and lamina propria (basal) compartments (Hecht, 1999; 268 
Madara, 1997). While IEC are reported to be unresponsive to LPS, Caco-2 cells have very 269 
low levels of tlr4 mRNA and weakly detectable md-2 expression when compare to human 270 
dermal microvessel endothelial cells (Abreu et al., 2001). We suggest that the uptake of 271 
OvES by host cells might depend on the presence of a specific receptor, such as TLR4, that is 272 
highly expressed on cholangiocytes compared to intestinal epithelial cells. 273 
To further address the mechanism of internalization of OvES products by different 274 
cell lines we analysed the role of the endocytic pathway. This pathway is the key process 275 
involved in the internalization of molecules from the cell surface to internal membrane 276 
compartments, and two major mechanisms are involved in this receptor-mediated endocytic 277 
pathway: clathrin-mediated endocytosis and the non-classical caveolae-mediated endocytosis 278 
(Le Roy and Wrana, 2005). Clathrin-mediated endocytosis requires clathrin and adaptor 279 
proteins such as AP-2 and Esp15 to form a coat pit (Keen, 1987), whereas the caveolae-280 
mediated pathway depends on the balance between the caveolin-1 protein and lipid raft 281 
components such as cholesterol and glycosphingolipids (Sharma et al., 2004). By using 282 
different endocytosis blocking agents such as CPZ, sucrose and filipin, we showed that CPZ 283 
and sucrose significantly blocked the internalization of OvES in all hepatic cell types studied. 284 
CPZ is known to cause a loss of clathrin-coated pits at cell surfaces and is associated with 285 
accumulation of clathrin and AP-2 in the endosomal compartment (DiPaola et al., 1984; 286 
Sofer and Futerman, 1995), while sucrose serves as a hypertonic medium and induces 287 
abnormal clathrin polymerization into empty microcages (Heuser and Anderson, 1989). 288 
Despite the requirement of clathrin-mediated endocytosis for internalization of OvES 289 
products, filipin, a sterol-binging agent that disrupts structure and function of caveolae 290 
(Orlandi and Fishman, 1998; Schnitzer et al., 1994) also blocked the uptake of OvES by 291 
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normal cholangiocytes (H69), but not by CCA cell lines. These results imply that different 292 
OvES proteins use different pathways to enter host cells, although clathrin-mediated 293 
endocytosis clearly plays a major role in the overall process.  294 
We have shown that OvES products specifically induce production of IL-6 by human 295 
cholangiocytes, but not by human colon cancer epithelial cells, suggesting that 296 
cholangiocytes might be the primary source of IL-6 in the biliary epithelium of infected 297 
individuals. High levels of IL-6 have been associated with chronic periductal fibrosis and 298 
CCA in opisthorchiasis patients (Sripa et al., 2012b). Moreover, IL-6 has also been 299 
implicated in the maintenance of chronic inflammation that could lead to tumorigenesis 300 
(Schafer and Werner, 2008). Thuwajit et al. reported that OvES products may act as growth 301 
factors by inducing proliferation of a mouse fibroblast cell line (NIH-3T3) in vitro 302 
accompanied by increased expression of the TGF-β receptor (TGFβR) (Thuwajit et al., 2004). 303 
Interestingly, clathrin- and caveolae-mediated endocytosis can regulate TGFβR signaling and 304 
turnover (Di Guglielmo et al., 2003). In addition, different internalization pathways are 305 
associated with distinct intercellular fates. Several signaling receptors, including TGFβR, 306 
receptor tyrosine kinases (RTKs), GPCRs, NOTCH and WNT are involved in both clathrin-307 
mediated endocytosis and non-clathrin endocytosis and influence the final signaling output 308 
(Le Roy and Wrana, 2005). Clathrin-mediated entry is associated with long-term signaling 309 
(Sadowski et al., 2009) whereas caveolae-mediated entry associated with Smad7-Smurf2 310 
ubiquitin ligase complex is directly involved in degradation of the receptor by lysosome (Di 311 
Guglielmo et al., 2003). OvES products stimulate cell proliferation and signal transduction 312 
via clathrin- and caveolae-mediated endocytosis in normal cholangiocytes but only the 313 
clathrin pathway in CCA cells. The endocytosis pathway regulates the balance in the receptor 314 
systems acting as an effector or attenuator of the signal transduction (Lipkowitz, 2003). Thus, 315 
the internalization of OvES via clathrin-mediated endocytosis may steer receptors away from 316 
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a degradation fate, and enhance signaling from the plasma membrane, thereby increasing 317 
inflammatory cascade signaling and contributing to the immunopathogenesis of 318 
opisthorchiasis. However, more studies are required to assess this hypothesis.  319 
We reveal here a role for the clathrin-mediated and caveolae endocytic pathways in 320 
the internalization of OvES by biliary epithelial cells, and subsequent stimulation of cell 321 
proliferation and the production of the pro-inflammatory cytokine IL-6. This is a key early 322 
step in pathogenesis of opisthorchiasis and CCA development, particularly seeing as 323 
inflammatory IL-6 can stimulate inflammation leading to free radical production causing 324 
oxidative DNA damage (Sripa et al., 2012). DNA damage can be from exogenous (i.e. 325 
nitrosamine in fermented dietary foods) or endogenous nitrosation from O. viverrini infection 326 
(Sripa et al., 2007). These biliary cells that have undergone DNA damage due to OvES 327 
exposure are induced to proliferate, and fixed genetic alterations ultimately occur. 328 
Accumulated genetic alterations can ensue with uncontrolled growth and subsequent 329 
malignancy. However, OvES also displays inhibitory effects on host cells, such as anti-330 
apoptotic activity (Sripa et al. 2012).  Further work is now required to characterize multiple 331 
pathways downstream of the process of parasite protein internalisation, as well as the 332 
individual fluke proteins involved and their cellular receptors. Recent reports have shown that 333 
parasitic helminths secrete extracellular vesicles (Buck et al., 2014; Marcilla et al., 2012), and 334 
future work should explore the possibility that O. viverrini secretes exosome-like vesicles 335 
that are internalized by host cells. A better understanding of the process of host cell-mediated 336 
internalization of liver fluke proteins will shed light on the immunopathogenesis of the 337 
infection and provide novel pathways to target in the development of vaccines against this 338 
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Figure Legends 478 
Fig. 1.  Internalization of O. viverrini ES products (OvES) by biliary cells (H69, KKU-479 
100, KKU-M156) and colon cancer cells (Caco-2) at 15, 30, 45 and 60 min post-480 
incubation.  Internalization of OvES (green fluorescence) by different cell types over time 481 
(A). Orthogonal views using Z-stack immunofluorescence microscopy showing 3-D 482 
internalization of OvES at 0 min (B), 15 min (C) and 120 min (D) in H69 cholangiocytes. 483 
Note that OvES is more readily internalized by biliary cells than by colonic epithelial cells. 484 
Nucleus was stained with propidium iodide (Red fluorescence). 485 
 486 
Fig. 2.  Mean intracellular fluorescence depicting the internalization of O. viverrini ES 487 
products (OvES) by normal cholangiocytes (H69), cholangiocarcinoma (KKU-100, 488 
KKU-M156) and colon cancer (Caco-2) cell lines over 2 h. Fluorescence intensity was 489 
measured by flow cytometry (A). Histogram is the average intensity of OvES internalization 490 
from 3 independent experiments ± SEM (B).   491 
 492 
Fig. 3.  Confocal fluorescence microscopy images showing internalization of O. viverrini 493 
ES products (OvES) in H69, KKU-100 and KKU-M156 biliary cells with and without 494 
endocytosis inhibitors. Cells treated with an inhibitor of the clathrin pathway 495 
(chlorpromazine, CPZ) showed reduced internalization of OvES (green fluorescence) in all 496 
cell types tested. Similarly, sucrose-treated cells showed substantially reduced internalization 497 
of OvES in the cholangiocarcinoma lines KKU-100 and KKU-M156 and partially reduced 498 
internalization in H69 cholangiocytes.  499 
 500 
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Fig. 4.  Endocytosis pathway inhibitors block the uptake of O. viverrini ES products 501 
(OvES) by normal (H69) and cholangiocarcinoma (KKU-100 and KKU-M156) biliary 502 
cell lines using flow cytometry. Cells were pretreated with the endocytosis inhibitors 503 
chlorpromazine (CPZ), sucrose (clathrin-mediated inhibitor) and filipin (caveolae-mediated 504 
inhibitor) before incubation with OvES for 2h. Fluorescence intensity was measured by flow 505 
cytometry (upper panel).  The histogram depicts the average of three independent 506 
experiments ± SEM (lower panel).   507 
 508 
Fig. 5.  Co-staining of H69 cholangiocytes for internalized O. viverrini ES products 509 
(OvES) and cell organelles revelaed an absence of co-localization. OvES is observed as 510 
punctate green fluorescence. Cells were co-stained for endoplasmic reticulum with ER-511 
Tracker-red (A), Golgi with Golgi-tracker-red (B), early endosomes with Anti-Rab5-red (C) 512 
and lysosomes with LysoTracker-red (D). Nuclei were counterstained with Hoechst dye 513 
(blue).  514 
 515 
Fig. 6.  Real time cell proliferation of biliary (H69, KKU-100, KKU-M156) and colon 516 
(Caco-2) cells induced by O. viverrini ES products (OvES) in the presence or absence of 517 
chlorpromazine using an xCELLigence system. OvES stimulated proliferation of bilary 518 
cells (A-C) but not colon cells (D) compared to media control over 96 h of culture. CPZ 519 
significantly inhibited growth of all cell types. Growth of each cell type was normalized to its 520 
media control without OvES.  521 
 522 
Fig. 7. IL-6 production. IL-6 production in normal human cholangiocytes (H69) and human 523 
colon cancer (Caco-2) cocultured with Opisthorchis viverrini excretory-secretory products 524 
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(OvES) in several dilutions for 48h (A). The biliary cells were strongly stimulated by OvES 525 
protein, but has no effected in colon cancer cell when compare with control cells. IL-6 526 
production from normal human cholangiocyte cell (H69) with and without endocytosis 527 
inhibitors (chlorpromazine; CPZ, Filipin and Bafilomycine A1) before OvES stimulated for 528 
48h using ELISA technique (B). OvES stimulated IL-6 production while all inhibitor of 529 
endocytosis suppressed the IL-6 secreted significantly. Histograms represent the average of 530 
three independent experiments ± SEM of the absorbance at 450 nm measured by Versamax 531 
microplate reader using SoftMax pro V.5 program (*** P< 0.001). 532 
 533 
Supplementary Figures 534 
Supplementary Fig. 1.  The kinetics of internalization of O. viverrini ES products (OvES) 535 
at 0, 15, 30, 45, 60 min in normal cholangiocytes (H69), cholangiocarcinoma cell lines 536 
(KKU-100 and KKU-M156) and Caco-2 colon cancer cells.  Histograms represent the 537 
average of three independent experiments ± SEM of the fluorescence intensity measured by 538 
flow cytometry.   539 
 540 
Supplementary Fig. 2.  Fluorescence intensity of internalization of O. viverrini ES 541 
products (OvES) by H69 cholagiocytes, KKU-100 and KKU-M156 cholangiocarcinoma 542 
cell with and without the endocytosis inhibitors cholorpromazine (CPZ) and sucrose. 543 
CPZ and sucrose have significant inhibitory effects on OvES internalization in all biliary cell 544 
types (A, B, C). Histograms represent the average of three independent experiments ± SEM 545 
of the fluorescence intensity measured by image analysis.  546 
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